Last week, the Standing Technical Sub-Committee of the NTAGI had recommended inclusion of the Serum Institute's Covovax in the national COV...

The COVID-19 Working Group has now recommended to the Standing Technical Sub-Committee of the National Technical Advisory Group on Immunisa...

The authorization is a global first for the age group for the vaccine, which is manufactured and marketed in India by the Serum Institute o...

India's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...

The lawmakers urged the President to use the two vaccines which are a result of India-US collaborations for the global good and to end vacc...

It is the fourth vaccine to receive the regulator's nod for use among those below 18 years.

The recommendation is yet to be approved by the DCGI. Pune-based SII had last month sought restricted emergency use of Covovax in adolescen...

"Data shows that in people who have taken Covishield, the protein vaccine Covovax works better as a booster than another dose of Covishield...

Both SII and Biological E are conducting Phase III trials of their vaccines on children. These could become the next choices of vaccines fo...

People in the government are hopeful that by the time vaccination starts for this age group, results of clinical trials of Covovax and Corb...

The government had placed an order for Corbevax even before it received emergency use authorisation (EUA). It paid ₹1,500 crore in advance ...

Booster doses will become available in India from January 10. The prioritisation and sequence of administration would be based on completin...

Union Health Minister Mansukh Mandaviya on Tuesday said that the Central Drug Authority CDSCO has approved the Serum Institute of India's C...

The recommendations have been sent to the Drug Controller General of India (DCGI), which will soon decide on their approval, people in the ...

The subject experts committee (SEC), a body under India's drug regulator, will meet on Monday to review the applications for granting appro...

This comes even as the government's advisory group on Covid-19 is awaiting data from the National Institute of Virology (NIV), Pune before ...

The approval for conducting phase III comparator safety and immunogenicity trial in adults came after the SEC's review of Phase I and II cl...